Evidence map›Paper›PMID 42426415›Full record

ArticlePharmaceutical research2026

Variance-Consistent Covariate Modeling from Posterior Summaries in Population Pharmacokinetics.

Junya Ooka, Mizuki Uno, Yuta Nakamaru, Yiran Song, Mengqi Fang, Kanako So, Tomoko Kita, Fumiyoshi Yamashita

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Junya OokaDepartment of Quantitative Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshidashimoadachi-Cho, Sakyo-Ku, Kyoto, 606-8501, Japan.
Mizuki UnoDepartment of Quantitative Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshidashimoadachi-Cho, Sakyo-Ku, Kyoto, 606-8501, Japan.
Yuta NakamaruDepartment of Quantitative Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshidashimoadachi-Cho, Sakyo-Ku, Kyoto, 606-8501, Japan.
Yiran SongDepartment of Quantitative Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshidashimoadachi-Cho, Sakyo-Ku, Kyoto, 606-8501, Japan.
Mengqi FangDepartment of Quantitative Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshidashimoadachi-Cho, Sakyo-Ku, Kyoto, 606-8501, Japan.
Kanako SoDepartment of Quantitative Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshidashimoadachi-Cho, Sakyo-Ku, Kyoto, 606-8501, Japan.
Tomoko KitaDepartment of Quantitative Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshidashimoadachi-Cho, Sakyo-Ku, Kyoto, 606-8501, Japan.
Fumiyoshi YamashitaDepartment of Quantitative Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshidashimoadachi-Cho, Sakyo-Ku, Kyoto, 606-8501, Japan. yama@pharm.kyoto-u.ac.jp.ORCID http://orcid.org/0000-0002-3503-8696

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSystematic covariate modeling in nonlinear mixed-effects (NLME) analysis is computationally intensive due to repeated refitting to concentration-time data. Although empirical Bayes estimates (EBEs) facilitate screening, η-shrinkage attenuates between-subject variability and distorts covariance structures, leading to shrinkage bias. We propose a variance-consistent framework enabling covariate modeling from a single base-model fit.

methodsThe proposed approach incorporates subject-specific posterior means and covariances from an NLME base model. A variance-matching penalty enforces consistency between the total between-subject covariance (model-explained and unexplained) and the base model estimates, preserving the covariance structure without refitting. Performance was compared with EBE regression, two-stage Bayesian estimation, and NLME covariate modeling. Stepwise covariate selection was evaluated using likelihood ratio tests, with the resulting structure compared against the NLME-identified structure as the gold-standard reference.

resultsUnder substantial η-shrinkage of approximately 30%, EBE regression and two-stage Bayesian estimation attenuated covariate-effect parameter estimates. The proposed method provided unbiased estimates, mitigating shrinkage bias and recovering covariate-effect parameter estimates obtained with NLME. It also reproduced NLME-based stepwise covariate selection with high computational scalability by avoiding repeated refitting to time-course data.

conclusionsVariance-consistent posterior-based covariate modeling provides a statistically coherent and computationally scalable framework for systematic covariate identification in population PKPD analysis.

Indexed as

Models, BiologicalPharmacokineticsBayes TheoremComputer SimulationHumansModels, StatisticalNonlinear Dynamicscovariate modelingempirical bayes estimatespopulation pharmacokineticsposterior summariesshrinkage bias

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.